Other
Therapeutic support
Therapeutic support is an intervention with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
unknown1
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
recruiting133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
NCT06706232
not_yet_recruitingnot_applicable
Therapeutic Support to Strengthen Dignity, Mental Well-being and Quality of Life in Acute Palliative Care Patients.
NCT06549075
unknown
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
NCT05548075
Clinical Trials (3)
Showing 3 of 3 trials
NCT06706232Phase 2
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
NCT06549075Not Applicable
Therapeutic Support to Strengthen Dignity, Mental Well-being and Quality of Life in Acute Palliative Care Patients.
NCT05548075
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3